Search results
Results from the WOW.Com Content Network
In the trial, Jardiance cut the combined risk of cardiovascular death or hospitalization from heart failure in HFpEF patients with or without diabetes. At the 26-month mark, 13.8% of Jardiance ...
Empagliflozin lowers risk of hospitalization and death in people with reduced heart function, when added to standard heart failure treatment with or without type 2 diabetes. [ 29 ] [ 30 ] [ 31 ] It is indicated in adults with type 2 diabetes and established cardiovascular disease to reduce the risk of cardiovascular death; and as an adjunct to ...
Men have a higher incidence of heart failure, but the overall prevalence rate is similar in both sexes since women survive longer after the onset of heart failure. [147] Women tend to be older when diagnosed with heart failure (after menopause), they are more likely than men to have diastolic dysfunction, and seem to experience a lower overall ...
Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors ...
The diabetes treatments Jardiance from Eli Lilly and Co. and Merck's Januvia made the list, along with Amgen’s autoimmune disease treatment Enbrel. Other drugs include Entresto from Novartis ...
Keeping your heart rate at 60 to 70 percent of its maximum allows for longer exercise without feeling worn out afterward. Heart Rate Zone 3. The intensity in Zone 3 is high enough to challenge you ...
In the Copenhagen City Heart Study a heart rate of 65 bpm rather than 80 bpm was associated with 4.6 years longer life expectancy in men and 3.6 years in women. [27] Other studies have shown all-cause mortality is increased by 1.22 (hazard ratio) when heart rate exceeds 90 beats per minute. [ 7 ]
A new study suggests that acetaminophen, also known as Tylenol, can cause complications in some people over age 65. Drs. Marc Siegel and Macie Smith comment on the findings.